Aeglea Biotherapeutics competitorsClear all

Aeglea Biotherapeutics's top competitors include Aptevo Therapeutics, Cleveland BioLabs, Immune Design and XBiotech.
Aeglea Biotherapeutics
Aeglea Biotherapeutics
Aeglea BioTherapeutics is a biotechnology company committed to developing enzyme-based therapeutics in the field of amino acid metabolism to treat rare genetic diseases and cancer.
Aptevo Therapeutics
Aptevo Therapeutics
Aptevo Therapeutics is a biotech company primarily focused on bringing novel oncology and hematology therapeutics to market.
Cleveland BioLabs
Cleveland BioLabs
CBLI’s mission is to develop and commercialize innovative drugs to treat cancer and protect healthy tissues from radiation, chemotherapy or ischemic conditions.
Immune Design
Immune Design
Immune Design develops vaccines and therapeutics for the prevention and treatment of infectious diseases.
XBiotech
XBiotech
XBiotech is a biopharmaceutical company developing first-in-class antibody therapies.
Founding Date
Founding Date
2013
Founding Date
2016
Founding Date
2003
Founding Date
2008
Founding Date
2005
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Austin, US HQ
Locations
Seattle, US HQ
Richmond, GB
Locations
Buffalo, US HQ
Locations
Seattle, US HQ
South San Francisco, US
Locations
Austin, US HQ
Employees
Employees
619% increase
Employees
1182% decrease
Employees
118% decrease
Employees
4813% decrease
Employees
595% increase
Valuation ($)
Valuation ($)
200.6 m
Valuation ($)
38.3 m
Valuation ($)
17.3 m
Valuation ($)
282.9 m
Valuation ($)
259.7 m
Alexa Website Rank
Alexa Website Rank
267354
Alexa Website Rank
310777
Alexa Website Rank
N/A
Alexa Website Rank
424902
Alexa Website Rank
99873

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$23.1m (FY, 2018)
Revenue (est.)
N/A
Revenue (est.)
$2.2m (FY, 2018)
Revenue (est.)
N/A
Cost of goods
Cost of goods
N/A
Cost of goods
$11.2m (FY, 2018)
Cost of goods
N/A
Cost of goods
$1.4m (FY, 2018)
Cost of goods
N/A
Gross profit
Gross profit
N/A
Gross profit
$11.9m (FY, 2018)
Gross profit
N/A
Gross profit
$761k (FY, 2018)
Gross profit
N/A
Net income
Net income
($44.3m) (FY, 2018)
Net income
($53.7m) (FY, 2018)
Net income
($3.7m) (FY, 2018)
Net income
($54.8m) (FY, 2018)
Net income
($21.1m) (FY, 2018)

Operating

Phase I Trials Products
Phase I Trials Products
2 (FY, 2016)
Phase I Trials Products
N/A
Phase I Trials Products
N/A
Phase I Trials Products
1 (FY, 2016)
Phase I Trials Products
N/A
For sources of this data, please see the company profile

View company profiles

Aptevo Therapeutics
HQ
Seattle, US
Employees
118↓ 2% decrease

Aptevo Therapeutics is a biotech company primarily focused on bringing novel oncology and hematology therapeutics to market.

View company
Cleveland BioLabs
HQ
Buffalo, US
Employees
11↓ 8% decrease

CBLI’s mission is to develop and commercialize innovative drugs to treat cancer and protect healthy tissues from radiation, chemotherapy or ischemic conditions.

View company
Immune Design
HQ
Seattle, US
Employees
48↓ 13% decrease

Immune Design develops vaccines and therapeutics for the prevention and treatment of infectious diseases.

View company
XBiotech
HQ
Austin, US
Employees
59↑ 5% increase

XBiotech is a biopharmaceutical company developing first-in-class antibody therapies.

View company